Acid Reflux Relief Pellet
NDC Package 61727-331-21
Package Information
Acid Reflux Relief (capsicum, sodium phosphate, dibasic, heptahydrate, strychnos nux-vomica seed, robinia pseudoacacia bark, sulfur, sepia officinalis juice) pellets is turn tube upside down, twist cap to break seal & release pellets. This formulation utilizes a pellet delivery system. Marketed by Homeocare Laboratories, this product is identified by NDC 61727-331.
Identification & Billing
Clinical Specifications
- Allergens - [CS]
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
- Vegetable Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 61727 - Homeocare Laboratories
- 61727-331 - Acid Reflux Relief
- 61727-331-21 - 4 g in 1 TUBE
- 61727-331 - Acid Reflux Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 61727-331-21 identifies a specific commercial package of 4 g in 1 tube of Acid Reflux Relief, a human over the counter drug labeled by Homeocare Laboratories. This pellet is formulated for sublingual use and contains capsicum; robinia pseudoacacia bark; sepia officinalis juice; sodium phosphate, dibasic, heptahydrate; strychnos nux-vomica seed; sulfur as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Homeocare Laboratories on June 08, 2012. The current certification is valid through December 31, 2026.
How is this Homeocare Laboratories product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 61727033121. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.